The Packed Bed Reactor Experiment (PBRE) is a basic science investigation designed to fill in the missing information as to how two-phase mixtures flow through porous media in microgravity.
DNDi has begun an implementation study of a recently-approved pediatric antiretroviral (ARV) treatment in order to address the urgent need for better medicines for children living with HIV. This study, which has begun in Kenya, is an important step towards DNDi's ultimate goal of developing, together with the Indian generic pharmaceutical company Cipla Ltd and in partnership with UNITAID, improved and easy-to-take combinations of the key HIV medicines children need to survive into adulthood.
Assurex Health, Inc. today announced a significant enhancement to its GeneSight® Psychotropic test giving healthcare providers an expanded range of options in helping to make medication decisions for patients suffering from depression, anxiety, bipolar disorder, posttraumatic stress disorder, schizophrenia, and other behavioral health conditions.
The Gerontological Society of America has announced a new partnership. The National Hartford Center of Gerontological Nursing Excellence will relocate to the Hartford Institute of Geriatric Nursing at the New York University College of Nursing, effective January 2016. This John A. Hartford Foundation grant-supported program has been based at GSA since 2012, focusing on preparing new academic gerontological nursing leaders and enhancing the gerontological nursing expertise of faculty.
Today the American Academy of Sleep Medicine announced that sleep medicine practices nationwide now can sign up for Tell A Sleep Doc, a new state-of-the-art telemedicine platform that will dramatically increase patient access to high quality health care provided by board-certified sleep medicine physicians and accredited sleep centers.
Elsevier, a world-leading provider of scientific, technical, and medical information products and services, today announced the launch of the American Journal of Ophthalmology Case Reports (www.ajocasereports.com), a new open access journal publishing case reports in all subspecialties within ophthalmology. This peer-reviewed, online-only companion journal to the prestigious American Journal of Ophthalmology (AJO) is now accepting submissions and will begin the publication of articles in 2016.
Millions of people are now living with -- rather than dying from -- HIV in Sub-Saharan Africa due to combination drug therapies. But the vast majority struggle to manage the many disabilities caused by this disease and its treatment. Today, University of Toronto researchers and their partners in Zambia, Kenya, South Africa and Canada launched a free website to help health workers improve the quality of life of adults and children living with HIV throughout Africa.
Few technologies have the power that particle accelerator technology has to touch upon such a broad range of applications at the many frontiers of modern science. Today, thanks to improvements in laser technology, a new generation of accelerators could soon emerge to replace accelerators relying on radio frequencies. They are presented in this special issue.
Elsevier, a world-leading provider of scientific, technical, and medical information products and services, today announced the launch of the American Journal of Ophthalmology Case Reports, a new open access journal publishing case reports in all subspecialties within ophthalmology. This peer-reviewed, online-only companion journal to the prestigious American Journal of Ophthalmology (AJO) is now accepting submissions and will begin the publication of articles in 2016.
Early trial results show significant clinical activity observed in the first human trial of pioneering personalized cancer treatment CXD101 in patients at Oxford's Churchill Hospital with advanced treatment-resistant aggressive disease. The results also indicate that CXD101 has favorable safety and tolerability.